NMC Health Plc (LSE:NMC) agreed to acquire the remaining 49% stake in Fakih IVF Group from Michael Fakih for approximately $210 million on January 4, 2018. NMC Health Plc will issue approximately 3.5 million shares at a price of $39.42 per share and the remaining consideration will be in cash. Post-acquisition, stake of NMC Health Plc in Fakih IVF Group will increase from 51% to 100%. The acquisition will be financed from existing cash resources and issuance of NMC Health Plc shares to Michael Fakih. Michael Fakih will retain his role as a Medical Director in NMC and continue his practice as a medical doctor. The acquisition has a high accretive value for the NMC Health Plc shareholders. Rindala Beydoun, Carlo Pianese, Emile Boulos, Celine Bsaibes, Maryline Kalaydjian and Shiladitya Majumdar of Tribonian Law Advisors acted as legal advisor to NMC Health Plc and Fakih IVF Group.